|
Volumn 21, Issue 16, 2011, Pages 4879-4883
|
Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture
|
Author keywords
1,2,4 Thiadiazolidine 3,5 diones; Acute myelogenous leukemia (AML); Antileukemic; Rapid cell death kinetics
|
Indexed keywords
1,2,4 THIADIAZOLIDINE 3,5 DIONE DERIVATIVE;
ANTILEUKEMIC AGENT;
THIAZOLIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CELL DEATH;
CELL VIABILITY;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG POTENCY;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL;
CELL DEATH;
CELL SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DISCOVERY;
HUMANS;
KINETICS;
LEUKEMIA, MYELOID, ACUTE;
MOLECULAR STRUCTURE;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIADIAZOLES;
TUMOR CELLS, CULTURED;
|
EID: 79960903704
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.06.027 Document Type: Article |
Times cited : (9)
|
References (13)
|